The Mayo Clinic Cancer Center (MCCC) has a robust planning and evaluation process in place across all of its sites. Dr. Diasio as Director leads a strong senior leadership team with each team member having a well- defined role and responsibilities. These include: Dr. Robert Smallridge as Deputy Director for Mayo Clinic in Florida (MCF), Dr. Aleksandar Sekulic as Deputy Director for Mayo Clinic in Arizona (MCA), Dr. Daniel Billadeau as Deputy Director for Basic Science, Dr. Steven Alberts as Deputy Director for Clinical Research, Dr. Gloria Petersen as Deputy Director for Population Sciences, Ms. Jane Welter as Deputy Director for Administration, Dr. Thomas Witzig as Associate Director for Translational Research, Dr. Aminah Jatoi as Associate Director for Research Education, and Dr. Carmen Radecki-Breitkopf as Associate Director for Cancer Disparities and Community Outreach. Members of the senior leadership team meet twice monthly; once as the senior most leadership committee made up of Director and Deputy Directors, the MCCC Executive Committee, and once as a larger group with the Associate Directors, the MCCC Research Committee. The MCCC Research Committee receives input from the Internal Scientific Advisory Committee and the Clinical Research Committee. Dr. Diasio and the Center receive advisory input internally from the Mayo Clinic Research Committee, directed by the Executive Dean for Research and externally from the External Advisory Committee made up of directors and senior leaders from other centers who provide expertise in the various program areas. The center also benefits from expertise provided by a Community Advisory Board made up of patients, family members of patients, and advocates in various cancer areas. Since the last competitive renewal, MCCC has conducted strategic planning that has resulted in a number of new research directions that have been undertaken leading to a number of new directions and accomplishments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015083-47
Application #
10113625
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-04-25
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
47
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Hu, G; Dasari, S; Asmann, Y W et al. (2018) Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma. Leukemia 32:565-569
Geller, James I; Fox, Elizabeth; Turpin, Brian K et al. (2018) A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315). Cancer 124:4548-4555
Luchtel, Rebecca A; Dasari, Surendra; Oishi, Naoki et al. (2018) Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Blood 132:1386-1398
Oishi, Naoki; Brody, Garry S; Ketterling, Rhett P et al. (2018) Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. Blood 132:544-547
DuBois, Steven G; Mosse, Yael P; Fox, Elizabeth et al. (2018) Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res 24:6142-6149
Farber, Benjamin A; Lalazar, Gadi; Simon, Elana P et al. (2018) Non coding RNA analysis in fibrolamellar hepatocellular carcinoma. Oncotarget 9:10211-10227
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Dasari, Surendra; Newsom, Sean A; Ehrlicher, Sarah E et al. (2018) Remodeling of skeletal muscle mitochondrial proteome with high-fat diet involves greater changes to ?-oxidation than electron transfer proteins in mice. Am J Physiol Endocrinol Metab 315:E425-E434
Nowsheen, Somaira; Aziz, Khaled; Aziz, Asef et al. (2018) L3MBTL2 orchestrates ubiquitin signalling by dictating the sequential recruitment of RNF8 and RNF168 after DNA damage. Nat Cell Biol 20:455-464
Razidlo, Gina L; Burton, Kevin M; McNiven, Mark A (2018) Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42. J Biol Chem 293:11143-11153

Showing the most recent 10 out of 1129 publications